Medicine and Dentistry Critical Reviews in Oncology/Hematology
January to December 2011 full year
1. Circulating microRNAs: Association with disease and potential use as biomarkers • Review article
Critical Reviews in Oncology/Hematology, Volume 80, Issue 2, 1 November 2011, Pages 193-208
2. Febrile neutropenia: A critical review of the initial management • Review article
Critical Reviews in Oncology/Hematology, Volume 78, Issue 3, 1 June 2011, Pages 185-194
3. Lymphoblastic lymphoma • Review article
Critical Reviews in Oncology/Hematology, Volume 79, Issue 3, 1 September 2011, Pages 330-343
4. Treatment of metastatic breast cancer: State-of-the-art, subtypes and perspectives • Review article
Critical Reviews in Oncology/Hematology, Volume 80, Issue 3, 1 December 2011, Pages 433-449
5. Mantle cell lymphoma: The promise of new treatment options • Review article
Critical Reviews in Oncology/Hematology, Volume 80, Issue 1, 1 October 2011, Pages 69-86
6. Stem cell origin of cancer and differentiation therapy • Review article
Critical Reviews in Oncology/Hematology, Volume 51, Issue 1, 1 July 2004, Pages 1-28
7. Colon cancer • Review article
Critical Reviews in Oncology/Hematology, Volume 74, Issue 2, 1 May 2010, Pages 106-133
8. Cancer cachexia: A systematic literature review of items and domains associated with involuntary weight loss in cancer • Review article
Critical Reviews in Oncology/Hematology, Volume 80, Issue 1, 1 October 2011, Pages 114-144
9. The inflammatory micro-environment in tumor progression: The role of tumor-associated macrophages • Review article
Critical Reviews in Oncology/Hematology, Volume 66, Issue 1, 1 April 2008, Pages 1-9
10. Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice • Review article
Critical Reviews in Oncology/Hematology
11. Current technologies for HER2 testing in breast cancer • Review article
Critical Reviews in Oncology/Hematology, Volume 80, Issue 3, 1 December 2011, Pages 380-392
12. Targeting immune suppressing myeloid-derived suppressor cells in oncology • Review article
Critical Reviews in Oncology/Hematology, Volume 77, Issue 1, 1 January 2011, Pages 12-19
13. Gastric cancer • Review article
Critical Reviews in Oncology/Hematology, Volume 71, Issue 2, 1 August 2009, Pages 127-164
14. Mechanisms of resistance to cisplatin and carboplatin • Review article
Critical Reviews in Oncology/Hematology
15. Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer • Review article
Critical Reviews in Oncology/Hematology, Volume 75, Issue 3, 1 September 2010, Pages 173-234
16. Treatment of acute lymphoblastic leukemia in adults • Review article
Critical Reviews in Oncology/Hematology, Volume 81, Issue 1, 1 January 2012, Pages 94-102
17. Disseminated and circulating tumor cells: Role in effective cancer management • Review article
Critical Reviews in Oncology/Hematology, Volume 77, Issue 1, 1 January 2011, Pages 1-11
18. Major and minor salivary gland tumors • Review article
Critical Reviews in Oncology/Hematology, Volume 74, Issue 2, 1 May 2010, Pages 134-148
19. Mantle cell lymphoma • Review article
Critical Reviews in Oncology/Hematology
20. Eribulin-A review of preclinical and clinical studies • Review article
Critical Reviews in Oncology/Hematology
21. Nickel essentiality, toxicity, and carcinogenicity • Review article
Critical Reviews in Oncology/Hematology, Volume 42, Issue 1, 1 April 2002, Pages 35 - 56
22. Necroptosis: An emerging form of programmed cell death • Review article
Critical Reviews in Oncology/Hematology
23. Malignant pleural mesothelioma: The standard of care and challenges for future management • Review article
Critical Reviews in Oncology/Hematology, Volume 78, Issue 2, 1 May 2011, Pages 92-111
24. Peripheral T-cell lymphoma - Not otherwise specified • Review article
Critical Reviews in Oncology/Hematology, Volume 79, Issue 3, 1 September 2011, Pages 321-329
25. Epigenetic biomarkers for human cancer: The time is now • Review article
Critical Reviews in Oncology/Hematology, Volume 68, Issue 1, 1 October 2008, Pages 1-11